[ Price : $8.95]
Harvard Medical School researchers say FDA should clearly indicate when it has extrapolated an approved drug indication from pivot...[ Price : $8.95]
CDER says it doesnt object to additional materials Covis Pharma wants to introduce at a hearing on the FDA proposal to withdraw ap...[ Price : $8.95]
FDA cautions that noninvasive prenatal screening tests can give false results that can lead to inappropriate decisions without a c...[ Price : $8.95]
FDA reiterates concerns with phosphatidylinositol 3-kinase (PI3K) inhibitors and their approval for treating hematological maligna...[ Price : $8.95]
Federal Register notice: FDA permanently debars Yvelice Villaman-Bencosme from providing services in any capacity to a person that...[ Price : $8.95]
Federal Register notice: FDA is revoking the emergency use authorizations on five no-longer-marketed Covid-19 tests.[ Price : $8.95]
Writing in an online Lancet Oncology article, FDA officials outline challenges with current PI3K inhibitors that have the agency r...[ Price : $8.95]
A Hogan Lovells analysis of FDAs recent guidance on clinical trial diversity plans says such plans should be an important part of ...